An eight-year-old boy’s sudden loss of mobility became the first real-world test of a biochemical discovery that may shape future treatments for rare mitochondrial diseases.
Diagnosed with a fatal condition called HPDL deficiency, the boy was…
An eight-year-old boy’s sudden loss of mobility became the first real-world test of a biochemical discovery that may shape future treatments for rare mitochondrial diseases.
Diagnosed with a fatal condition called HPDL deficiency, the boy was…